Naturis Cosmetics is a proven contract manufacturer for beauty and personal care brands. Naturis Cosmetics has raised ₹100 crore in its first institutional funding round. Sharrp Ventures led the core capital investment. This is a significant career achievement for the company. A second strong investor who backed the funding round was the Mirabilis Investment Trust, on behalf of the family office of Infosys co-founder K. Dinesh.

Investor participation and operational overview

The maiden institutional round also received a varied mix of established institutional investors and industry leaders, in addition to the anchor investments from Sharrp Ventures and Mirabilis Investment Trust. Some of the prominent investors in the financing round include Anicut Capital, Niveshaay, and Hyperscale Ventures’ founder Suyash Saraf. 

Yogesh Kabra and a number of angel investors from the pharmaceutical and specialist chemicals industries contributed to the capital round. The widespread investment also indicates strong commercial confidence in the company’s manufacturing capacity and its core business model in the larger cosmetic/personal care market.

Naturis Cosmetics is an industry-familiar research and development-driven contract development and manufacturing organization (CDMO). The firm is a specialized operational model that collaborates with over 50 leading beauty and personal care brands.

It has a large network of partners including established consumer companies like Nykaa, Pilgrim, Purplle, Colorbar, Bare Anatomy, Kay Beauty, and Asaya. Apart from cosmetics, Naturis Cosmetics also co-develops with well-known pharmaceutical companies such as Glenmark and Dr. Reddy’s Laboratories, particularly for the over-the-counter and cosmeceutical business segments.

Capital allocation and financial performance

The subscription of additional capital worth ₹100 crore will be utilized to support the company’s next round of growth in terms of infrastructure and operations. The funds from the offering will be dedicated to a major building expansion and research initiative at Naturis Cosmetics’ manufacturing facilities. 

The capital would finance the establishment of a new manufacturing center at Vapi. The company intends to set up a separate experience centre in the national capital region and a new research and development centre in Mumbai. 

Some of the funds will also help the company continue to diversify into additional beauty, personal care and OTC product categories. This new investment arrives when the company’s financial performance is strong. Naturis Cosmetics has not officially released its FY26 financial performance.

The company’s operating revenue rose by around 40% to ₹154 crore during FY25 from a previous fiscal year figure of ₹110 crore. Naturis Cosmetics was making a profit, with total profits reaching ₹12 crore. The platform has registered a steady revenue growth rate of over 50% CAGR over the past 4 years and is profitably progressive according to corporate data.

Conclusion

With this ₹100 crore first institutional round, Naturis Cosmetics is well-positioned to leverage the large beauty and personal care manufacturing industry. The company has successfully established a viable business with highly profitable operations that offered compound annual growth through research-driven contract manufacturing. The startup is currently ready to build deeper partnerships with some of the biggest cosmetic companies as well as foreign pharmaceutical giants, and in a couple of years, with new sites in Vapi, Mumbai, and the NCR, it will enable sustained dominance in the Indian manufacturing market.